Walleye Trading
FPRX

Walleye Trading’s Five Prime Therapeutics, Inc. FPRX Stock Holding History

Walleye Trading’s Portfolio FPRX Stock Details FPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-2,000
Closed -$19K – 5003
2018
Q4 		$19K Buy
+2,000
New +$23.8K ﹤0.01% 4351
2018
Q3 		– Sell
-26,800
Closed -$424K – 5674
2018
Q2 		$424K Buy
26,800
+21,800
+436% +$380K ﹤0.01% 2989
2018
Q1 		$86K Buy
+5,000
New +$97.5K ﹤0.01% 3971

Other funds holding FPRX

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Walleye Trading's FPRX Position: Q1 2020 in Review

Walleye Trading sold out of Five Prime Therapeutics, Inc. (FPRX) in Q1 2020, closing a stake of 23,764 shares — an estimated $109K sold.

Walleye Trading first reported a position in FPRX in Q2 2015 and held it in 9 quarters. The position peaked at $543K in Q4 2018. 87 funds tracked by Wall St. Rank hold FPRX as of Q1 2020.

  • Walleye Trading reported no remaining Five Prime Therapeutics, Inc. position as of Q1 2020 after selling out during the quarter.
  • Walleye Trading sold 23,764 Five Prime Therapeutics, Inc. shares in Q1 2020, an estimated $109K.
  • Walleye Trading first reported a position in Five Prime Therapeutics, Inc. in Q2 2015 and held it in 9 quarters.
  • Walleye Trading's Five Prime Therapeutics, Inc. position peaked at $543K in Q4 2018.
  • 87 funds tracked by Wall St. Rank held Five Prime Therapeutics, Inc. as of Q1 2020.

Based on Walleye Trading's 13F filing for Q1 2020, filed 15 May 2020.